Print Version
Office of Research, Impact and Postgraduate Studies
presents a Postgraduate Seminar on
The Status of Prostate Cancer
by Dr. Nuneaton RamesarProstate Cancer (PC) is one of the main causes of cancer death worldwide. The mortality rate for PC in the Caribbean is higher than in many developed countries, and there is a disparity in incidence among the different Caribbean nations.
Trinidad and Tobago has the highest incidence of prostate cancer among men, which is 44.4%, according to the GLOBOCAN (2020) database. Apart from surveillance and screening, this situation raises concerns about genetic and other risk factors causing PC incidence. PC research is limited in scope and regularity in the Caribbean, creating a literature gap.
The findings from the literature review conducted on PC in the Caribbean demonstrated that the countries with low resources, are burdened by more severe diseases with worse PC outcomes. Furthermore, territories with national cancer registries appeared to have improved methods for PC management. This review is important, because it provides initial support for researchers, administrators, and planners for PC healthcare.
Based on this review, a study will be conducted to investigate genetic and other risk factors for PC patients in medical clinics from the different Regional Health Authorities (RHAs) throughout Trinidad and Tobago (TT).
Additionally, the objectives of the study will be fulfilled by collecting data from blood samples taken by a trained phlebotomist, relevant data from the cancer registry, records in the medical clinics and laboratories, and answers given in a seven-part designed questionnaire. This study will be a quantitative type of cross-sectional study.
Analysis of the findings can identify genetic and other risk factors for PC specific to PC high-risk males in TT. This can lead to more targeted prevention and treatment, thereby enhancing PC care and reducing the burden placed on TT society.
Further research should concentrate on prevention strategies and the standardisation of treatment procedures to improve surveillance and enhance patient outcomes.

Dr. Nuneaton Ramesar is a two-time graduate of The University of The West Indies (UWI). He holds a Bachelor of Medicine and Bachelor of Surgery, and a Master of Public Health. He also holds a Master of Science with Distinction in Occupational Health, Safety, and Environment from the University of Greenwich. He worked at Port-of-Spain General Hospital, and Arima Hospital for six years from 1993. Subsequently, he left these hospitals and has his own general practice located in Arima.
For the past six years, Dr. Ramesar has worked in the fields of public health, medical research, and occupational health, where he has developed skills in research methodology, data analysis, and ethical application. Additionally, he is enrolled in a Ph.D. programme in Biomedical Engineering at The University of Trinidad and Tobago (UTT).
Dr. Ramesar is presently a private medical general practitioner in Arima. He diagnoses and treats a wide range of patients from babies to elderly persons. Furthermore, he conducts cancer screening, obstetric and gynaecological care, executive medicals, occupational medicals for various industries, blood tests, electrocardiography, and minor surgeries including medical aesthetic procedures.
In his leisure time, he enjoys reading and travelling, as well as attending conferences and seminars on the most recent trends and advancements in the medical field. He hopes that the findings of this study can direct interventions to improve care for prostate cancer patients.